Finance

Beta
Lists
4014:TADAWUL
Scientific and Mdcl Eqpmnt Hs Cmpny CJSC
SAR 30.48
-0.91%
(-0.28) 1D
Jun 4, 3:17:26 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4014...
Open
SAR 30.80
High
SAR 30.80
Low
SAR 30.40
Mkt. cap
914.40M
Avg. vol.
43.54K
Volume
27.98K
Dividend
3.28%
Quarterly dividend
SAR 0.25
Ex-dividend date
Jun 17, 2026
P/E ratio
31.50
52-wk high
SAR 41.00
52-wk low
SAR 26.00
EPS
SAR 0.97
Shares outstanding
24.19M
No. of employees
6K
Open
SAR 30.80
High
SAR 30.80
Low
SAR 30.40
Mkt. cap
914.40M
Avg. vol.
43.54K
Volume
27.98K
Dividend
3.28%
Quarterly dividend
SAR 0.25
Ex-dividend date
Jun 17, 2026
P/E ratio
31.50
52-wk high
SAR 41.00
52-wk low
SAR 26.00
EPS
SAR 0.97
Shares outstanding
24.19M
No. of employees
6K
News stories
From sources across the web
About Scientific and Mdcl Eqpmnt Hs Cmpny CJSC
CEO-
Employees6.02K
Founded1979
Headquarters-
SectorHealth care provider
Previous reportsAll values in SAR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SAR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
272.04M
200.52M
181.92M
192.09M
Cost of goods sold
233.29M
171.90M
161.48M
180.58M
Cost of revenue
233.29M
171.90M
161.48M
180.58M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.39M
21.23M
18.23M
-
Operating expense
22.74M
21.71M
21.23M
-
Total operating expenses
256.04M
193.61M
182.71M
180.58M
Operating income
16.00M
6.91M
-787.84K
11.51M
Other non operating income
4.17M
4.50M
7.82M
332.00K
EBT including unusual items
16.62M
8.20M
3.22M
11.84M
EBT excluding unusual items
16.41M
7.85M
2.97M
11.84M
Income tax expense
4.84M
1.33M
2.94M
3.56M
Effective tax rate
29.15%
16.27%
91.32%
30.08%
Other operating expenses
-
-
-
-
Net income
12.37M
7.67M
711.58K
8.28M
Net profit margin
4.55%
3.82%
0.39%
4.31%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-3.76M
-3.57M
-4.06M
-
Net interest expenses
-3.76M
-3.57M
-4.06M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
18.89M
9.25M
1.19M
13.93M
Gain or loss from assets sale
-213.99K
-340.12K
-267.91K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more